Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,219 | -1,841 | -7,844 | -5,116 | -2,923 |
| Depreciation Amortization | 3 | 1 | 5 | 4 | 3 |
| Accounts receivable | -3 | 3 | -7 | -14 | -29 |
| Other Working Capital | 62 | -128 | 341 | 34 | -95 |
| Other Operating Activity | 313 | 194 | 836 | 691 | 415 |
| Operating Cash Flow | $-2,845 | $-1,770 | $-6,669 | $-4,402 | $-2,628 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,982 | 1,645 | 6,724 | 6,671 | 6,594 |
| Other Financing Activity | 0 | -473 | 485 | 0 | 0 |
| Financing Cash Flow | $1,982 | $1,172 | $7,209 | $6,671 | $6,594 |
| Beginning Cash Position | 1,787 | 1,798 | 1,304 | 1,293 | 1,310 |
| End Cash Position | 924 | 1,200 | 1,844 | 3,562 | 5,275 |
| Net Cash Flow | $-862 | $-598 | $540 | $2,269 | $3,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,845 | -1,770 | -6,669 | -4,402 | -2,628 |
| Free Cash Flow | -2,845 | -1,770 | -6,669 | -4,402 | -2,628 |